News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Lipodystrophy news

Show

From To
Support issues for children and young people
Young adults who were infected at birth: the complexities of lifelong HIV are increasingly apparent

Although 85% of young adults who take antiretroviral therapy have an undetectable viral load, the complexities and complications of lifelong HIV infection are becoming increasingly apparent, researchers told

Published
11 April 2011
By
Roger Pebody
New and experimental HIV treatments
What Lies Ahead: An Activist's View of Promising HIV Treatment Research

After attending the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) in Boston, Mass., and following different areas of research, I decided to write down a list of advancements that really thrill and energize me as an educator and research advocate.

Published
31 March 2011
From
The Body
Ageing and HIV
Decreased limb muscle and increased abdominal fat linked to higher mortality in people with HIV

HIV-positive people who lose muscle mass in their arms and legs whilst gaining abdominal fat have a higher likelihood of death, according to findings from the FRAM

Published
02 March 2011
By
Liz Highleyman
Side-effects
European Medicines Agency: d4T to be used only in last resort

The European Medicines Agency has issued new guidance on the use of d4T (stavudine, Zerit), saying that the drug should be used only when no other alternative

Published
21 February 2011
By
Keith Alcorn
HIV treatment
European regulator restricts use of d4T (stavudine, Zerit)

In view of the side effects seen with the medicine, the CHMP recommended that the marketing authorisation for Zerit should be renewed with restrictions. The Committee recommended that, for both adults and children, it should be used for as short a time as possible and only when there are no appropriate alternatives.

Published
18 February 2011
From
European Medicines Agency
Lipodystrophy
HIV Lipo Drug Egrifta Now Available; Financial Assistance Programs Open

Egrifta (tesamorelin), the lipodystrophy treatment approved by the U.S. Food and Drug Administration (FDA) late last year, is now officially available to people living with HIV and their health care providers, according to EMD Serono.

Published
27 January 2011
From
AIDSMeds
Side-effects
Reconstructive surgery for facial fat loss is feasible and safe for patients with HIV

Reconstructive surgery is “a well tolerated, feasible tool to treat HIV-related face lipoatrophy”, according to an international team of investigators writing in the online edition of AIDS.

Published
02 November 2010
By
Michael Carter
HIV treatment for children and young people
Children with HIV are at risk for metabolic problems and heart muscle dysfunction

More than half of European children infected with HIV through mother-to-child transmission show signs of metabolic abnormalities, including body fat changes and elevated blood lipid levels that

Published
21 July 2010
By
Liz Highleyman
Lipodystrophy
Fat loss caused by some anti-HIV drugs persists in the long term

The fat loss that can be caused by some anti-HIV drugs appears to persist in the long term despite discontinuation of the drugs that cause

Published
31 May 2010
By
Michael Carter
Lipodystrophy
Body fat changes in people with HIV: a clinical review

This article reviews the antiretroviral side-effect of lipoatrophy (fat loss) in resource-limited settings.

Published
18 December 2009
From
HIV & AIDS treatment in practice
← Prev1...34567Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.